Table 5 Integrin expression and disease free survival
Integrin | Median DFS (95% CI) in months | Â | |
|---|---|---|---|
| Â | Low expression* | High expression | P |
Alpha1 | 14.8 (0.0-64.2) | 18.4 (8.3-28.5) | Ns |
Alpha2 | 20.8 (0.0-46.5) | 18.4 (9.1-27.7) | Ns |
Alpha3 | 32.8 (0.0-73.3) | 13.0 (8.5-17.4) | Ns |
Alpha4 | 13.8 (0.0-29.4) | 18.6 (2.6-34.6) | Ns |
Alpha5 | 32.8 (5.7-59.9) | 10.0 (8.4-11.6) | 0.018 |
Alpha6 | 20.8 (10.1-31.5) | 26.4 (2.2-50.6) | Ns |
Alpha7 | 18.6 (1.0-36.5) | 20.8 (0.0-42.0) | Ns |
Alpha11 | 20.8 (3.4-38.2) | 26.4 (0.0-58.5) | Ns |
AlphaV | 14.8 (0.0-37.1) | 18.4 (8.6-28.2) | Ns |
Beta1 | 61.8 (8.6-115.0) | 12.4 (8.2-16.7) | 0.012 |
Beta3 | 32.8 (0.0-79.4) | 9.9 (2.8-17.1) | 0.022 |
Beta4 | 20.9 (7.4-34.4) | 13.0 (4.3-21.7) | Ns |
Beta5 | 14.8 (2.0-27.7) | 20.8 (0.0-46.1) | Ns |
Beta6 | 26.4 (12.0-40.8) | 14.8 (2.6-27.0) | Ns |
Beta8 | 10.7 (0.0-25.0) | 26.4 (4.2-48.6) | Ns |